The FDA published a comprehensive listing of recognized voluntary consensus standards related to pharmaceutical quality guidance from their Drug Evaluation and Research (CDER) program. This program facilitates submissions by external stakeholders and FDA staff proposing voluntary consensus standards related to pharmaceutical quality for recognition. CDER believes that this program will help promote beneficial innovation in pharmaceutical development and manufacturing and streamline the preparation and assessment of marketing applications for products regulated by CDER.
Read the full guidance here.